Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Medicago
About
Medicago is a biotechnology company focused on the research, development, production, and commercialization of vaccines in Canada.
- 501 - 1000
Highlights
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $25M
- Industries
- Biotechnology,Commercial,Health Care,Medical
- Founded date
- Jan 1, 1997
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
Medicago Inc., a biotechnology company, focuses on the research, development, production, and commercialization of vaccines in Canada. The company develops its vaccines based on its proprietary technologies, including the plant-based Proficia technology and Virus-Like Particles (VLP) technology. Its product candidate includes H5N1 pandemic influenza VLP vaccine, which has completed a Phase I human clinical trial. The company is also developing H1N1 VLP vaccine for Influenza A/California/04/09 virus; and seasonal influenza vaccines. Medicago Inc. has collaboration agreements with Viridis S.A.; Genopole biopark to manufacture pandemic and seasonal influenza vaccines; and Philip Morris International to produce a therapeutic protein with a humancompatible glycosylation pattern. The company was incorporated in 1997 and is headquartered in Quebec City, Canada.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 27, 2011 | Post-IPO Equity | $25M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
AgeChem Venture Fund
|
— | Post-IPO Equity |
